Research programme: monoclonal antibody BC1 - Antisoma
Alternative Names: HuBC-1; huMabBC1; Humanised monoclonal antibody BC1; Monoclonal antibody BC-1Latest Information Update: 02 Oct 2021
At a glance
- Originator Istituto Nazionale per la Ricerca Sul Cancro
- Class Monoclonal antibodies
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 07 Aug 2006 Discontinued - Preclinical for Solid tumours in United Kingdom (Parenteral)
- 30 Jun 2002 Preclinical trials in Solid tumours in United Kingdom (Parenteral)